Jürgen Braun
Impact in
- Rheumatology top 0.01%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 518
- Spondyloarthritis Studies and Treatments 468
- Rheumatoid Arthritis Research and Therapies 234
- Systemic Lupus Erythematosus Research 25
- Immunology 147
- Psoriasis: Treatment and Pathogenesis 123
- Biosimilars and Bioanalytical Methods 17
- Co-authors
- Joachim Sieper (191 shared papers)Désirée van der Heijde (109 shared papers)Xenofon Baraliakos (200 shared papers)Martín Rudwaleit (88 shared papers)Joachim Listing (47 shared papers)J. Brandt (27 shared papers)Hildrun Haibel (35 shared papers)Maxime Dougados (28 shared papers)
- Journals
- Annals of the Rheumatic Diseases (139 papers)Lara D. Veeken (32 papers)RMD Open (25 papers)The Journal of Rheumatology (23 papers)Arthritis Care & Research (11 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Jürgen Braun
566 papers receiving 31.4k citations
Jürgen Braun's Hit Papers
Peers
Comparison fields: 5 of 172
- Rheumatology 27.1k
- Hematology 5.1k
- Immunology 9.3k
- Orthopedics and Sports Medicine 2.4k
- Complementary and Manual Therapy 134
Countries citing papers authored by Jürgen Braun
This map shows the geographic impact of Jürgen Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Braun more than expected).
Fields of papers citing papers by Jürgen Braun
This network shows the impact of papers produced by Jürgen Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Braun. The network helps show where Jürgen Braun may publish in the future.
Co-authors
The 25 scholars most cited alongside Jürgen Braun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 606 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ankylosing spondylitis Hit paper breakdown → | 2007 | 1429 |
| 2 | The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis Hit paper breakdown → | 2009 | 1201 |
| 3 | Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Hit paper breakdown → | 2002 | 1006 |
| 4 | Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis Hit paper breakdown → | 2015 | 768 |
| 5 | Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Hit paper breakdown → | 2006 | 689 |
| 6 | Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Hit paper breakdown → | 2009 | 684 |
| 7 | Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis Hit paper breakdown → | 2003 | 682 |
| 8 | Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT) Hit paper breakdown → | 2005 | 679 |
| 9 | Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial Hit paper breakdown → | 2003 | 610 |
| 10 | Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores Hit paper breakdown → | 2010 | 575 |
| 11 | Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis Hit paper breakdown → | 1995 | 573 |
| 12 | The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort Hit paper breakdown → | 2009 | 539 |
| 13 | Ankylosing spondylitis: an overview Hit paper breakdown → | 2002 | 501 |
| 14 | Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial Hit paper breakdown → | 2008 | 464 |
| 15 | A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study Hit paper breakdown → | 2013 | 463 |
| 16 | 2006 | 411 | |
| 17 | Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 400 |
| 18 | 2003 | 370 | |
| 19 | Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study Hit paper breakdown → | 2013 | 362 |
| 20 | Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis Hit paper breakdown → | 2011 | 349 |
About Jürgen Braun
Jürgen Braun is a scholar working on Rheumatology, Immunology, Hematology, Orthopedics and Sports Medicine and Pathology and Forensic Medicine, having authored 606 papers that have together received 33.1k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (468 papers), Rheumatoid Arthritis Research and Therapies (234 papers), Psoriasis: Treatment and Pathogenesis (123 papers), Autoimmune and Inflammatory Disorders Research (59 papers), Bone and Joint Diseases (51 papers), Systemic Lupus Erythematosus Research (25 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (23 papers) and Biosimilars and Bioanalytical Methods (17 papers). The work is most often cited by research in Rheumatology (27.1k citations), Hematology (5.1k citations), Immunology (9.3k citations), Orthopedics and Sports Medicine (2.4k citations) and Complementary and Manual Therapy (134 citations). Jürgen Braun has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Joachim Sieper, Désirée van der Heijde, Xenofon Baraliakos, Martín Rudwaleit, Joachim Listing, J. Brandt, Hildrun Haibel, Maxime Dougados, John C. Davis and Walter P. Maksymowych. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, RMD Open, The Journal of Rheumatology and Arthritis Care & Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.